Results 131 to 140 of about 1,550,569 (253)
Repurposing FDA‐Approved Drugs to Inhibit Fungal PPTases for Broad‐Spectrum Synergy
Fungal secondary metabolites serve as crucial virulence effectors; however, the potential of their biosynthetic pathways as antifungal targets remains inadequately comprehended. Repurposed FDA‐approved drugs inhibit fungal PPTase (essential for secondary metabolism) in vivo.
Zili Song +7 more
wiley +1 more source
Study of Factors to Increase the Usage Rate of Generic Drugs in Platelet Aggregation Inhibitors. [PDF]
Suzuki T +9 more
europepmc +1 more source
Low‐dose electron holography is limited by shot noise, which buries weak phase signals. HoloDenoiser, a physics‐informed network that works simultaneously in the spatial and frequency domains, locates and protects the holographic sideband while suppressing noise in the hologram.
Ye Luo +10 more
wiley +1 more source
Letter to the editor: Editorial: Opinion of patients seeking primary care regarding prescription of generic drugs: A cross-sectional study. [PDF]
Zhang G.
europepmc +1 more source
After oral administration, inodorous GLU‐BA self‐assembles into nanomicelles in aqueous environments to resist premature gastric adsorption. Upon reaching the intestine, endogenous esterases rapidly cleave the built‐in ester bonds in these nanomicelles to release BA and GLU, with GLU further metabolized by gut microbiota to gradually generate BA ...
Feifei Xin +9 more
wiley +1 more source
Assessment of community pharmacists' knowledge of the differences between generic drugs and biosimilars: A pilot cross-sectional study. [PDF]
Awada S +4 more
europepmc +1 more source
Oligosaccharides with defined glycosidic bonds drive divergent gut microbial succession and shape unique metabolic profiles. Absolute time‐series profiling with Bayesian generalized Lotka–Volterra modeling identifies bond‐specific microbial responders, while monoculture validation and metaproteomics reveal linkage‐matched transport and cleavage modules.
Xiaoxuan Lu +10 more
wiley +1 more source
Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs. [PDF]
Liu J, Zhang Y, Kaplan CM.
europepmc +1 more source
Generic Competition for Drugs Treating Rare Diseases
Prescription drugs are usually very expensive until patents on the brandname product expire, but prices of many older off-patent medicines have risen in recent years in the absence of effective generic competition.
Kesselheim, Aaron
core
Non‐canonical amino acids (ncAAs) enhance peptide therapeutics but remain difficult to model computationally. SinCAA, a similarity‐enhanced pretraining framework, jointly optimizes contrastive learning guided by a novel conformational similarity metric with masked node reconstruction, capturing both functional relationships and chemical identity of ...
Chencheng Xu +8 more
wiley +1 more source

